ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Lupus"

  • Abstract Number: 006 • 2020 Pediatric Rheumatology Symposium

    Increasing Rates of Standardized Depression Screening in Youth with Systemic Lupus Erythematosus in a Pediatric Rheumatology Clinic

    Victoria Newsome 1, Jodi Dingle 2, Manda Mitchell 3, Thomas Brent Graham 4 and Alaina Davis5, 1Nashville, 2Vanderbilt University Medical Center, Nashville, Tennessee, 3Nashville, Tennessee, 4Vanderbilt University Medical Center, Nashville, 5Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, Tennessee

    Background/Purpose: Depression is common among youth with SLE.  Early identification and treatment of depression has the potential to improve health outcomes for youth with SLE.…
  • Abstract Number: 031 • 2020 Pediatric Rheumatology Symposium

    Exome Sequencing for Early Pediatric Systemic Lupus Erythematosus: Standard of Care in 2020?

    Yike Jiang1, Bo Yuan 1, Marietta DeGuzman 1, M. Cecilia Poli 2, Justin Branch 1, Andrea Ramirez 3, Martha Curry 1, Maria Pereira 4, Amanda Brown 1, W. Blaine Lapin 5, Sarah Nicholas 1, Lisa Forbes 1, Nicholas Rider 1, Levi Watkin 1, Jennifer Rammel 6, Ankur Kamdar 7, Melissa Mizesko 8, Juan Carlos Becerra 9, Emilina Lim 10, Eyal Muscal 11, Anaid Reyes 1, Zeynep Coban-Akdemir 1, James Lupski 1, Ivan Chinn 1 and Tiphanie Vogel 1, 1Baylor College of Medicine, Houston, 2Universidad del Desarrollo, Santiago, Chile, 3Section of Rheumatology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, 4Assistant Professor, Section of Rheumatology, Division of Pediatrics, Baylor College of Medicine, Houston, Texas, 5, 6Section of Nephrology and Rheumatology, Department of Pediatrics, University of Florida Health Jacksonville, Jacksonville, Florida, 7Houston, 8Driscoll Children's Hospital, Corpus Christi, 9Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru, 10Children's Hospital Orange County, Orange County, 11Section of Rheumatology, Department of Pediatrics, Baylor College of Medicine, houston

    Background/Purpose: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease with multifactorial etiology. Identification of monogenic causes of pediatric SLE (pSLE) has yielded important insights…
  • Abstract Number: 071 • 2020 Pediatric Rheumatology Symposium

    Patient Reported Outcomes and Resilience in Pediatric Systemic Lupus Erythematosus

    Lauren Ambler1, Rula Issa 2, Stephanie Pan 2 and Rebecca Trachtman 2, 1Mount Sinai Hospital, New York, 2Icahn School of Medicine at Mount Sinai, New York

    Background/Purpose: It has been established that pediatric Systemic Lupus Erythematous (pSLE) is associated with lower health-related quality of life (HRQOL); however, there are few studies…
  • Abstract Number: 088 • 2020 Pediatric Rheumatology Symposium

    Sun Protection Use in Patients Followed in a Pediatric Rheumatology Clinic in an Urban Setting

    Tamara Tanner1, Gabriel Tarshish 2, Dawn Wahezi 3 and Tamar Rubinstein 4, 1Montefiore Medical Center, Bronx, 2Children's Hospital at Montefiore, New York, 3Children's Hospital at Montefiore, Bronx, 4Albert Einstein College of Medicine, White Plains

    Background/Purpose: Exposure to sunlight has been implicated as a major contributing factor in the pathogenesis of systemic lupus erythematosus (SLE) and juvenile dermatomyositis (JDM). Despite…
  • Abstract Number: 168 • 2020 Pediatric Rheumatology Symposium

    Examining the Role of IFN-I and Langerhans Cell ADAM17 in Lupus Photosensitivity

    Keila Veiga1, Noa Schwartz 2, William Shipman 1, Marvin Sandoval 3, Thomas Li 1, Yurii Chinenov 1, David Oliver 1, Ali Jabbari 4, James Krueger 5, Sarah Taber 1, Niroshana Anandasabapathy 6 and Theresa Lu 1, 1Hospital for Special Surgery, New York, 2Albert Einstein College of Medicine/Montefiore Medical Center, New York, 3Weill Cornell Graduate School of Medical Sciences, New York, 4University of Iowa, Iowa City, 5Rockefeller Center, New York, 6Weill Cornell Medicine, New York

    Background/Purpose: Photosensitivity resulting in inflammatory skin lesions is a hallmark of cutaneous lupus.  Lesions can be disfiguring and have a negative impact on quality of…
  • Abstract Number: 689 • 2019 ACR/ARP Annual Meeting

    Patterns of High Disease Activity Status and Outcomes in Systemic Lupus Erythematosus

    Alberta Hoi 1, Hieu Nim 2, Rachel Koelmeyer 2, Ying Sun 3, Amy Kao 4, Oliver Guenther 3 and Eric Morand2, 1School of Clinical Sciences, Monash University, Meloburne, Victoria, Australia, 2Monash University, Melbourne, Victoria, Australia, 3Merck Healthcare KGaA, Darmstadt, Germany, 4EMD Serono Research & Development Institute, Inc., Billerica, MA

    Background/Purpose: High Disease Activity Status (HDAS), defined as ever attainment of SLEDAI-2k of 10 or greater, may be a useful indicator of overall disease severity in…
  • Abstract Number: 1199 • 2019 ACR/ARP Annual Meeting

    Improving Rates of Cervical Cancer Screening and HPV Vaccination in Patients with Lupus

    Nancy Desai1, Hanni Menn-Josephy 1, Ramon Bonegio 1, Christina Lam 1, Anna Kancharla 1 and Michael York 1, 1Boston Medical Center, Boston

    Background/Purpose: Patients with lupus have higher rates of cervical dysplasia and pre-malignant cervical lesions. At our institution, an urban referral center for patients with lupus, rates…
  • Abstract Number: 1734 • 2019 ACR/ARP Annual Meeting

    Low Bone Mineral Density Was Associated with Lupus Nephritis Irrespective of Duration on Steroid Treatment in a Large Observational Study of Juvenile Systemic Lupus Erythematosus Patients

    Anastasia-vasiliki Madenidou1, Yasmin Mahfouz 2, Oliver Cheng 2, Farah El-Sharnouby 2, Charlene Foley 2 and Coziana Ciurtin 3, 1Centre for Adolescent Rheumatology, University College London London, UK, LOndon, 2Centre for Adolescent Rheumatology, University College London London, UK, London, United Kingdom, 3Centre for Adolescent Rheumatology, University College London London, UK, Londond, United Kingdom

    Background/Purpose: An estimated 10-20% of all patients with systemic lupus erythematosus (SLE) develop clinical disease before the age of 18 years and are therefore classified…
  • Abstract Number: 2584 • 2019 ACR/ARP Annual Meeting

    Management of Cutaneous Manifestations of Lupus Erythematosus: A Systematic Review

    Jessica Fairley1, Shereen Oon 2, Amanda Saracino 3 and Mandana Nikpour 2, 1Monash University, Melbourne, Australia, 2St Vincent's Hospital, Melbourne; The University of Melbourne, Melbourne, Australia, 3University College London, London, United Kingdom

    Background/Purpose: Cutaneous lupus erythematosus (CLE), occurring with or without systemic lupus erythematosus (SLE), is a group of inflammatory skin diseases that can be very debilitating,…
  • Abstract Number: 691 • 2019 ACR/ARP Annual Meeting

    Adjusted GAPSS in Systemic Lupus Erythematosus Patients in Argentina

    Lucila Garcia1, Maria Victoria Martire 1, Sofia Velloso 1, Florencia Savy 1, Fernando Arizpe 2, Nadia Garcia 1, Adriana Testi 1, Claudia Pena 1, Dafne Capelusnik 3, Carolina Ayelen Isnardi 4, Victoria Collado 5, MARIA FLORENCIA Rodriguez 6, Cecilia Pisoni 7, Susana Mazza 8, Yessika Soria Curi 8, Adriana Seewald 9, María de la Torre 7 and Mercedes Garcia 10, 1Hospital San Martin, La Plata, Argentina, 2Hospital San Martin, Buenos Aires, Argentina, 3Instituto de Rehabilitacion Psicofisica, CABA, Ciudad Autonoma de Buenos Aires, Argentina, 4Instituto de Rehabilitación Psicofísica, Ciudad de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, 5Private clinic, buenos aires, Argentina, 6hospital rivadavia, buenos aires, Argentina, 7Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (CEMIC), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 8Hospital Ángel C. Padilla, San Miguel de Tucumán, Tucuman, Argentina, 9Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas, Argentina, 10Hospital San Martín, La Plata, Argentina

    Background/Purpose: Assessment of risk both for pregnancy morbidity and thrombosis in the presence of anti-phospholipid antibodies (aPL) is still a challenge. The Global Antiphospholipid Syndrome…
  • Abstract Number: 1561 • 2019 ACR/ARP Annual Meeting

    Decreased Nocturnal Blood Pressure Dipping in Patients with Systemic Lupus Erythematosus: Association with Markers of Inflammation

    Daniel Carranza Leon1, Annette Oeser 1, Qiong Wu 1, C. Michael Stein 2, Michelle Ormseth 1 and Cecilia Chung 2, 1Vanderbilt University Medical Center, Nashville, 2Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Blood pressure follows a circadian rhythm; usually systolic blood pressure (SBP) drops by more than 10% during the night. Absence of this phenomenon, known…
  • Abstract Number: 1786 • 2019 ACR/ARP Annual Meeting

    Surrogate Pathways of Complement Activation in Novel Polygenic SLE-like Models of Kidney Injury

    Sladjana Skopelja-Gardner1, Xizhang Sun 2, Yufeng Peng 2, Lucrezia Colonna 2, Payton Hermanson 2, Lena Tanaka 2, Joyce Tai 2, David Salant 3 and Keith Elkon 2, 1University of Washington, Seattle, WA, 2University of Washington, Seattle, 3Boston University, Boston

    Background/Purpose: Lupus nephritis (LN) is a major contributor to morbidity and mortality in systemic lupus erythematosus (SLE). Defective clearance of apoptotic cells (AC), autoantibodies, and…
  • Abstract Number: 2782 • 2019 ACR/ARP Annual Meeting

    Comparative Risks of Cardiovascular Disease Among SLE Patients Receiving Immunosuppressive Medications

    Daniel Li1, Candace Feldman 1, Hongshu Guan 1, Brendan Everett 2, Seoyoung C. Kim 3 and Karen Costenbader 2, 1Brigham and Women's Hospital, Boston, 2Brigham and Women's Hospital, Boston, MA, 3Brigham and Women’s Hospital and Harvard Medical School, Boston

    Background/Purpose: Human studies examining cardiovascular disease (CVD) risk associated with immunosuppressants (IS) have been limited, but mycophenolate mofetil (MMF) was shown to suppress vascular smooth muscle…
  • Abstract Number: 694 • 2019 ACR/ARP Annual Meeting

    Body Mass Index at Time of Diagnosis Is Predictive of Future Disease Activity in SLE

    George Stojan1, Jessica Li 2 and Michelle Petri 2, 1Johns Hopkins University, Baltimore, MD, 2Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Obesity is more common in patients with SLE compared to the general population. The prevalence of obesity among SLE patients is between 28 and…
  • Abstract Number: 1568 • 2019 ACR/ARP Annual Meeting

    High Risk Low Attenuation Non-Calcified Coronary Plaque in Lupus vs. Controls

    George Stojan1, Jessica Li 2 and Michelle Petri 2, 1Johns Hopkins University, Baltimore, MD, 2Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: The presence of low attenuation noncalcified plaque (< 30 Haunsfield units) is one of the most characteristic vessel changes in unstable coronary plaques. Low-attenuation…
  • 1
  • 2
  • 3
  • …
  • 31
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.